|
|
| Research article summary (published 13 Oct 2009): |
STAT3 activation contributes directly to Epstein-Barr virus-mediated invasiveness of nasopharyngeal cancer cells in vitro.
Full Abstract
Nasopharyngeal cancer (NPC) is an Epstein-Barr virus (EBV)-associated head and neck cancer prevalent in Asia. Although with reasons not fully understood, the intrinsic invasiveness of NPC is believed to be EBV-linked. Recently, EBV was found to induce STAT3 activation. Constitutive STAT3 activation correlated with advanced clinical staging in NPC. We hypothesized that STAT3 activation by EBV directly contributes to the intrinsic invasiveness of NPC cells. Phospho-STAT3-Tyr705 was detected in high percentage of NPC tumors (7/10 cases). Using a paired NPC cell line model, HONE-1 and the EBV-infected counterpart, HONE-1-EBV, we found that HONE-1-EBV expressed a higher level of phospho-STAT3-Tyr705 and was approximately 11-fold more invasive than HONE-1. In HONE-1-EBV, STAT3 siRNA targeting inhibited both spontaneous and serum-induced invasion, as well as cell growth. Conversely, activation of STAT3 (by expressing an activated STAT3 mutant, namely STAT3C) in the parental HONE-1, mimicking EBV-induced STAT3 activation, significantly enhanced its invasiveness and proliferation, which was accompanied by increased expression of markers of mesenchymal status, proliferation and anti-apoptosis. Our results demonstrated that EBV-induced STAT3 activation is responsible for NPC cell proliferation and invasion. This was further confirmed by a small molecule inhibitor of JAK/STAT3, JSI-124. JSI-124 inhibited STAT3 activation in HONE-1-EBV, with subsequent growth inhibition, induction of PARP cleavage, abrogation of anchorage-independent growth and invasion. We found that EBV-independent activation of STAT3 by a growth factor, EGF, also contributed to NPC invasion. In conclusion, EBV-induced STAT3 activation directly contributes to the intrinsic invasiveness of NPC cells and STAT3 targeting may be beneficial in treating aggressive NPC.
Author information
Author/s: Lui, Vivian Wai Yan (VW); Wong, Elaine Yue Ling (EY); Ho, Yeung (Y); Hong, Bo (B); Wong, Sze Chuen Cesar (SC); Tao, Qian (Q); Choi, Gigi Ching Gee (GC); Au, Thomas Chi Chuen (TC); Ho, Kakiu (K); Yau, Daisy Mei Sze (DM); Ma, Brigette Buig Yue (BB); Hui, Edwin Pun (EP); Chan, Andrew Sai-Kit (AS); Tsang, Chi-Man (CM); Tsao, Sai-Wah (SW); Grandis, Jennifer Rubin (JR); Chan, Anthony Tak-Cheung (AT);
Affiliation: Cancer Signaling Laboratory, State Key Laboratory of Oncology in South China, Department of Clinical Oncology, Sir YK Pao Center for Cancer, Hong Kong Cancer Institute, The Chinese University of Hong Kong, Shatin, Hong Kong SAR, China.
Journal and publication information
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal: International journal of cancer. Journal international du cancer (Int J Cancer), published in United States. (Language: eng)
Reference: 2009-Oct; vol 125 (issue 8) : pp 1884-93
Dates: Created 2009/08/26; Completed 2009/09/21;
PMID: 19588483, status: MEDLINE (last retrieval date: 9/21/2009, IMS Date: )
Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.
External Links for this article
(including full text providers, if available):
Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.
This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.
MeSH headings (categories)
This article was linked to the MESH Headings shown below.
Related articles
These are the highest related articles currently in the database:
- Involvement of the Epstein-Barr virus in the nasopharyngeal carcinoma pathogenesis.
30 Dec 2004 - Association of Epstein-Barr virus infection with p53 protein accumulation but not bcl-2 protein in nasopharyngeal carcinoma.
29 Apr 1999 - Epstein-Barr virus (EBV) and human disease: facts, opinions and problems.
30 Mar 2000 - Differential signaling pathways are activated in the Epstein-Barr virus-associated malignancies nasopharyngeal carcinoma and Hodgkin lymphoma.
30 Jul 2004 - Immunohistochemical absence of CD21 membrane receptor in nasopharyngeal carcinoma cells infected by Epstein-Barr virus in Spanish patients.
29 Nov 2000 - Focus on nasopharyngeal carcinoma.
29 Apr 2004 - Nasopharyngeal/nasal type T/NK lymphomas: analysis of 14 cases and review of the literature.
29 Apr 2003 - Nuclear accumulation of epidermal growth factor receptor and acceleration of G1/S stage by Epstein-Barr-encoded oncoprotein latent membrane protein 1.
9 Nov 2004 - [Effects of LMP-1 expression on neoplastic cell proliferation and apoptosis in nasopharyngeal carcinoma]
29 Sep 1999 - BZLF1 controlled by family repeat domain induces lytic cytotoxicity in Epstein-Barr virus-positive tumor cells.
30 Dec 2003
Related Article Map
Legend:
- FREE Full text Article.
- Abstract only.
- Title only. More help.
See a large map of 100+ related articles.